The Vancouver-BOLD Study: The Burden of Chronic Obstructive Lung Disease

Overview

This is a study of the lung health of the population of Vancouver and the extent of, and the risk factors for, chronic obstructive lung disease.

Full Title of Study: “The Burden of Chronic Obstructive Lung Disease (BOLD) Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: December 2013

Interventions

  • Behavioral: Study to determine the burden of disease

Clinical Trial Outcome Measures

Primary Measures

  • Lung health
    • Time Frame: 10 years
    • Lung health of the population of Vancouver and the extent of, and the risk factors for, chronic obstructive lung disease

Participating in This Clinical Trial

Inclusion Criteria

  • 40 years of age and older
  • Both sexes
  • Random sample of population

Exclusion Criteria

  • Contraindication for lung function testing and serious life threatening illness.

Gender Eligibility: All

Minimum Age: 40 Years

Maximum Age: 90 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of British Columbia
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Wen Wang, Study Director, University of British Columbia

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.